Matthew Phillip Sinnreich serves as Executive at Organicell Regenerative Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Matthew Phillip Sinnreich has executed 3 insider transactions totaling $800, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 31, 2022 involved transacting 6,979 shares valued at $0.
Matthew Phillip Sinnreich currently holds 6,976,000 shares of Organicell Regenerative Medicine, Inc. (OCEL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Phillip Sinnreich has been a net seller of OCEL stock. They have purchased $0 and sold $800 worth of shares.
Matthew Phillip Sinnreich's most recent insider trade was on Oct 31, 2022, when they sold 6,979 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 13, 2022 | OCEL | $800 | Sale | 20,000 | $0.04 | Discretionary |